TEAM

TEAM CAR-NK


“Off-the-Shelf”


NK Platform

Our newly developed allogeneic NK cell line (NK101) with the best-in-class scalability ensures large-scale production of NK cells of uniform quality for clinical use.


“Poly-functional”


NK Cell Line

NK101 cell line retains functional characteristics of CD56dimCD62L+ NK cells, possessing the capacity to kill and produce cytokines at the same time.

NK-CAR


(Passive Immunotherapy)

Allogeneic NK cell line armed with 4th generation CAR composed of
NK cell-specific signaling domains and CAR-inducible cytokine secretion system for adoptive immunotherapy.

TEAM eMSC